Cargando…
Niclosamide as a Promising Therapeutic Player in Human Cancer and Other Diseases
Niclosamide is an FDA-approved anthelmintic drug for the treatment of parasitic infections. However, over the past few years, increasing evidence has shown that niclosamide could treat diseases beyond parasitic diseases, which include metabolic diseases, immune system diseases, bacterial and viral i...
Autores principales: | Wang, Zhan, Ren, Junyi, Du, Jinxiu, Wang, Huan, Liu, Jia, Wang, Guiling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782559/ https://www.ncbi.nlm.nih.gov/pubmed/36555754 http://dx.doi.org/10.3390/ijms232416116 |
Ejemplares similares
-
Niclosamide—A promising treatment for COVID‐19
por: Singh, Shivani, et al.
Publicado: (2022) -
Niclosamide (NA) overcomes cisplatin resistance in human ovarian cancer
por: Huang, Linjuan, et al.
Publicado: (2023) -
Niclosamide: Beyond an antihelminthic drug
por: Chen, Wei, et al.
Publicado: (2018) -
Design, Synthesis, and Evaluation of Niclosamide Analogs as Therapeutic Agents for Enzalutamide-Resistant Prostate Cancer
por: Kang, Borui, et al.
Publicado: (2023) -
Antitumor effect and metabonomics of niclosamide micelles
por: Hang, Jiarong, et al.
Publicado: (2022)